Hi, what are you looking for?
L.A. County sues Roblox, alleges platform makes it easy for adults to target children
CFTC chief sides with prediction markets over state regulators in a high-stakes court case
Warner Bros. Discovery reopens talks with Paramount
Justice Department’s antitrust chief says she’s leaving, effective immediately
Cardi B’s cameo in Bad Bunny’s Super Bowl halftime show leads to dispute on prediction markets
New Found Gold Grade Control Drilling Continues to Deliver At-Surface High Grade Gold over Broad Widths at Queensway:
With Step-Out Drilling Continuing, Radisson Demonstrates Meaningful Resource Growth at O’Brien with an Updated Mineral Resource Estimate
Allied Critical Metals Delivers Robust Initial PEA at the Borralha Project
Closing date for director nominations
Crypto Market Update: Iran Conflict Pushes Bitcoin Further Under US$67K
Chart Mania – 23 ATR Move in QQQ – Metals Lead 2025 – XLV Oversold – XLU Breakout – ITB Moment of Truth
S&P 500 Breaking Out Again: What This Means for Your Portfolio
Momentum Leaders Are Rotating — Here’s How to Find Them
Is META Breaking Out or Breaking Down?
A Wild Ride For the History Books: 2025 Mid-Year Recap
Former President Bill Clinton deposed in Epstein probe in potential first for Congress
House Republicans push Johnson to go to war with Senate over SAVE Act
Tomahawks, B-2 stealth bombers and attack drones pound over 1,000 Iranian targets in 24-hour blitz
Trump pledges to ‘avenge’ fallen US service members as tensions with Iran intensify
Hormuz erupts: Attacks, GPS jamming, Houthi threats rock Strait amid US-Israeli strikes
Joe Cavatoni, senior market strategist, Americas, at the World Gold Council, looks back on gold’s performance in 2025 and forward to what could be coming in 2026.
In his view, risk and uncertainty are key gold drivers that are likely to stay in place next year.
Securities Disclosure: I, Charlotte McLeod, hold no direct investment interest in any company mentioned in this article.
Radiopharm Theranostics (ASX:RAD, ‘Radiopharm’ or the ‘Company’), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need,...
Is the market’s next surge already underway? Find out with Tom Bowley’s breakdown of where the money is flowing now and how you can get...
The chart of Meta Platforms, Inc. (META) has completed a roundtrip from the February high around $740 to the April low at $480 and...
The S&P 500 ($SPX) just logged its fifth straight trading box breakout, which means that, of the five trading ranges the index has experienced since...